http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108440577-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108440577-B
titleOfInvention Mixed copper-based complex and preparation method and application thereof
abstract The invention discloses a mixed copper-based complex and a preparation method and application thereof. The structural formula of the mixed copper-based complex is [ Cu (C) 10 H 10 NO 5 SBr)(C 12 H 8 N 2 )]·CH 3 OH, wherein [ Cu (C) 10 H 10 NO 5 SBr)(C 12 H 8 N 2 )]Is a coordination unit, C 10 H 10 NO 5 SBr is a Schiff base anionic ligand, C 12 H 8 N 2 Is a neutral ligand 1,10' -phenanthroline. The preparation method comprises the steps of mixing taurine and strong base, adding an organic solvent, stirring for dissolving, then adding 5-bromo-2-hydroxy-3-methoxybenzaldehyde, stirring for 2-4 hours at a constant temperature, stopping reaction, and obtaining potassium salt K of the ligand 2 C 10 H 10 NO 5 SBr; then the potassium salt K of the ligand 2 C 10 H 10 NO 5 And mixing SBr and copper salt, dissolving in a mixed solvent of methanol/water, adding 1,10' -phenanthroline, reacting at constant temperature for 8-20 h, and obtaining the mixed copper-based complex after the reaction is finished. The mixed copper-based complex is a candidate of an anti-tumor medicament, is a good tumor angiogenesis inhibitor, and is a candidate of a novel bifunctional anti-tumor medicament.
priorityDate 2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID337132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25203914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454066690
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481107
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14668
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4R4H7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452833283
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25673
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48036
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70075
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415910943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID262238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18616
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID308
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP17153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447669256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546721
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R1W0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1123

Total number of triples: 46.